A. Poveda

714 total citations
17 papers, 113 citations indexed

About

A. Poveda is a scholar working on Reproductive Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Poveda has authored 17 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Poveda's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). A. Poveda is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). A. Poveda collaborates with scholars based in Spain, Italy and Sweden. A. Poveda's co-authors include Ignace Vergote, Andrés Cervantes, Giovanna Scarfone, Frank G. Haluska, Paul Hoskins, Josep M. del Campo, S. Pecorelli, Ivana Teodorović, Benjamin Schwartz and L Ševčík and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

A. Poveda

15 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Poveda Spain 7 56 43 37 34 32 17 113
Katharina Leitner Austria 7 35 0.6× 44 1.0× 42 1.1× 12 0.4× 51 1.6× 20 149
Bernhard Krämer Germany 7 79 1.4× 57 1.3× 21 0.6× 11 0.3× 23 0.7× 22 130
Angela Jain United States 4 35 0.6× 15 0.3× 23 0.6× 12 0.4× 20 0.6× 14 68
Anne Sophie V M van den Heerik Netherlands 4 61 1.1× 101 2.3× 19 0.5× 23 0.7× 43 1.3× 4 151
Reena Merard United Kingdom 6 38 0.7× 21 0.5× 17 0.5× 13 0.4× 15 0.5× 7 80
Ana Santaballa Bertrán Spain 5 40 0.7× 9 0.2× 30 0.8× 9 0.3× 18 0.6× 11 81
Cecilia M. Dorfling South Africa 3 36 0.6× 59 1.4× 12 0.3× 40 1.2× 14 0.4× 3 89
Sarah Farooq United States 6 32 0.6× 11 0.3× 64 1.7× 25 0.7× 19 0.6× 10 84
Marie Ange Mouret‐Reynier France 2 47 0.8× 8 0.2× 117 3.2× 25 0.7× 53 1.7× 3 149
Jean Siedel United States 3 20 0.4× 13 0.3× 34 0.9× 17 0.5× 11 0.3× 13 69

Countries citing papers authored by A. Poveda

Since Specialization
Citations

This map shows the geographic impact of A. Poveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Poveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Poveda more than expected).

Fields of papers citing papers by A. Poveda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Poveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Poveda. The network helps show where A. Poveda may publish in the future.

Co-authorship network of co-authors of A. Poveda

This figure shows the co-authorship network connecting the top 25 collaborators of A. Poveda. A scholar is included among the top collaborators of A. Poveda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Poveda. A. Poveda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Andrade, Jurandyr Moreira de, et al.. (2018). Neoadjuvant chemotherapy and radical surgery versus chemorradiation for stage IB2, IIA2 e IIB cervical cancer: A randomized controlled trial. Annals of Oncology. 29. viii357–viii358. 1 indexed citations
2.
Brotto, Lori A., Michael Brundage, Paul Hoskins, et al.. (2015). Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life. Supportive Care in Cancer. 24(3). 1241–1249. 17 indexed citations
3.
Martín‐Broto, Javier, Silvia Calabuig‐Fariñas, Antonio Gutiérrez, et al.. (2014). Integrating Genotype in Risk Classification for Gist Recurrence. a Spanish Group for Sarcoma Research (Geis) Study. Annals of Oncology. 25. iv495–iv495. 2 indexed citations
4.
Oza, Amit M., A. Poveda, Sandro Pignata, et al.. (2011). A randomized phase II (RP2) trial of ridaforolimus (R) compared with progestin (P) or chemotheraphy (C) in female adult patients with advanced endometrial carcinoma.. Journal of Clinical Oncology. 29(15_suppl). 5009–5009. 25 indexed citations
5.
Poveda, A., B.J. Monk, S. B. Kaye, et al.. (2011). Prediction of progression-free survival (PFS) adjusted by continuous platinum-free interval (PFI) at fixed timepoints in patients with recurrent ovarian cancer (ROC): Results from OVA-301.. Journal of Clinical Oncology. 29(15_suppl). 5067–5067. 2 indexed citations
6.
Poveda, A., et al.. (2010). Tumor adenomatoide de túnica albugínea. Caso clínico. Actas Urológicas Españolas. 34(2). 208–209.
7.
Poveda, A., et al.. (2010). Penile metastasis of esophageal scamous cell carcinoma. Actas Urológicas Españolas (English Edition). 34(3). 297–299. 1 indexed citations
8.
Poveda, A., et al.. (2010). Metástasis peneana de carcinoma epidermoide de esófago. Actas Urológicas Españolas. 34(3). 297–299.
9.
10.
Biron, Pierre, Peter Reichardt, Federica Grosso, et al.. (2007). A phase II study of gimatecan as salvage treatment in patients with advanced or metastatic soft tissue sarcoma (STS) relapsing after anthracycline / ifosfamide - based chemotherapy regimens. Journal of Clinical Oncology. 25(18_suppl). 10063–10063. 1 indexed citations
11.
Pecorelli, S., Isabelle Ray‐Coquard, Nicoletta Colombo, et al.. (2006). A phase II study of oral gimatecan (ST1481) in women with progressing or recurring advanced epithelial ovarian, fallopian tube and peritoneal cancers. Journal of Clinical Oncology. 24(18_suppl). 5088–5088. 6 indexed citations
12.
Roszak, A., Tudor–Eliade Ciuleanu, Mariusz Bidziński, et al.. (2006). Phase II open label randomized study of trabectedin (T) given as two different dosing schedules in women with platinum-sensitive, recurrent ovarian carcinoma: Preliminary results. Journal of Clinical Oncology. 24(18_suppl). 5031–5031. 11 indexed citations
13.
Poveda, A.. (2005). Gemcitabine in patients with ovarian cancer. Cancer Treatment Reviews. 31. S29–S37. 7 indexed citations
14.
Poveda, A.. (2003). Ovarian cancer treatment: what is new. International Journal of Gynecological Cancer. 13. 241–250. 5 indexed citations
15.
Reed, Nicholas S., Costantino Mangioni, Henric Malmström, et al.. (2003). First Results of a Randomised Trial Comparing Radiotherapy Versus- Observation Post Operatively in Patients With Uterine Sarcomas. An EORTC-GCG Study. International Journal of Gynecological Cancer. 13. 4–4. 19 indexed citations
16.
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Leitner Breakdown of academic impact, for papers by Bernhard Krämer Breakdown of academic impact, for papers by Angela Jain Breakdown of academic impact, for papers by Anne Sophie V M van den Heerik Breakdown of academic impact, for papers by Reena Merard Breakdown of academic impact, for papers by Ana Santaballa Bertrán Breakdown of academic impact, for papers by Cecilia M. Dorfling Breakdown of academic impact, for papers by Sarah Farooq Breakdown of academic impact, for papers by Marie Ange Mouret‐Reynier Breakdown of academic impact, for papers by Jean Siedel
Rankless by CCL
2026